PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ABL Diagnostics Société anonyme (ABLD.PA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

FR001400AHX6

Sector

Healthcare

Highlights

Market Cap

€40.56M

EPS (TTM)

€0.01

PE Ratio

252.00

Year Range

€2.50 - €9.70

Target Price

€6.01

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of €10,000 in ABL Diagnostics Société anonyme, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-80.00%-60.00%-40.00%-20.00%0.00%20.00%40.00%60.00%JulyAugustSeptemberOctoberNovemberDecember
-78.89%
53.97%
ABLD.PA (ABL Diagnostics Société anonyme)
Benchmark (^GSPC)

Returns By Period

ABL Diagnostics Société anonyme had a return of -74.23% year-to-date (YTD) and -74.23% in the last 12 months.


ABLD.PA

YTD

-74.23%

1M

-12.59%

6M

-16.67%

1Y

-74.23%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

24.34%

1M

0.23%

6M

8.53%

1Y

24.95%

5Y*

13.01%

10Y*

11.06%

Monthly Returns

The table below presents the monthly returns of ABLD.PA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20240.00%0.00%-67.22%-3.77%-0.65%-7.89%-1.43%0.72%4.32%-1.38%-0.70%-74.23%
20230.00%-26.55%-33.33%0.00%50.00%1.15%10.23%0.00%0.00%0.00%0.00%-18.10%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ABLD.PA is 7, meaning it’s performing worse than 93% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of ABLD.PA is 77
Overall Rank
The Sharpe Ratio Rank of ABLD.PA is 44
Sharpe Ratio Rank
The Sortino Ratio Rank of ABLD.PA is 99
Sortino Ratio Rank
The Omega Ratio Rank of ABLD.PA is 00
Omega Ratio Rank
The Calmar Ratio Rank of ABLD.PA is 22
Calmar Ratio Rank
The Martin Ratio Rank of ABLD.PA is 2020
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for ABL Diagnostics Société anonyme (ABLD.PA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for ABLD.PA, currently valued at -1.06, compared to the broader market-4.00-2.000.002.00-1.062.10
The chart of Sortino ratio for ABLD.PA, currently valued at -1.29, compared to the broader market-4.00-2.000.002.004.00-1.292.80
The chart of Omega ratio for ABLD.PA, currently valued at 0.28, compared to the broader market0.501.001.502.000.281.39
The chart of Calmar ratio for ABLD.PA, currently valued at -0.94, compared to the broader market0.002.004.006.00-0.943.09
The chart of Martin ratio for ABLD.PA, currently valued at -1.19, compared to the broader market-5.000.005.0010.0015.0020.0025.00-1.1913.49
ABLD.PA
^GSPC

The current ABL Diagnostics Société anonyme Sharpe ratio is -1.06. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of ABL Diagnostics Société anonyme with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
-1.06
2.48
ABLD.PA (ABL Diagnostics Société anonyme)
Benchmark (^GSPC)

Dividends

Dividend History

ABL Diagnostics Société anonyme provided a 0.00% dividend yield over the last twelve months, with an annual payout of €0.00 per share.


0.00%€0.00€0.50€1.00€1.50€2.002020202120222023
Dividends
Dividend Yield
PeriodTTM2023202220212020
Dividend€0.00€0.00€0.00€0.00€2.31

Dividend yield

0.00%0.00%0.00%0.00%0.00%

Monthly Dividends

The table displays the monthly dividend distributions for ABL Diagnostics Société anonyme. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00
2023€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00
2022€0.00€0.00
2020€2.31€2.31

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-78.89%
-1.93%
ABLD.PA (ABL Diagnostics Société anonyme)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the ABL Diagnostics Société anonyme. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the ABL Diagnostics Société anonyme was 78.89%, occurring on Dec 17, 2024. The portfolio has not yet recovered.

The current ABL Diagnostics Société anonyme drawdown is 78.89%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-78.89%Mar 9, 2023441Dec 17, 2024

Volatility

Volatility Chart

The current ABL Diagnostics Société anonyme volatility is 10.97%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%2.00%4.00%6.00%8.00%10.00%JulyAugustSeptemberOctoberNovemberDecember
10.97%
3.43%
ABLD.PA (ABL Diagnostics Société anonyme)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of ABL Diagnostics Société anonyme over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for ABL Diagnostics Société anonyme.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab